On April 17, 2024, The Panel Granted The Request Of VSAC To Continue Its Listing On The Nasdaq Stock Market Subject To The Condition That On Or Before July 15, 2024, The Co Will Transfer Its Listing From The Nasdaq Global Market To The Nasdaq Capital Market And Comply With All The Applicable Listing Requirements Of The Nasdaq Capital Market
Portfolio Pulse from Benzinga Newsdesk
Vision Sensing Acquisition Corp. (VSAC) has been granted an extension by the Nasdaq Hearings Panel to continue its listing on the Nasdaq Stock Market, with the condition to transfer its listing to the Nasdaq Capital Market by July 15, 2024, and comply with all applicable listing requirements. This decision follows VSAC's appeal and submission of a Compliance Plan addressing deficiencies in market value and total holders requirements, and the non-filing of its Form 10-Q for Q3 2023. VSAC regained compliance with the filing requirement on February 7, 2024, and plans to resolve other deficiencies through a business combination with Mediforum Co., Ltd. and other measures.
April 19, 2024 | 7:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
VSAC has been granted an extension to continue its Nasdaq listing, with conditions to transfer to the Nasdaq Capital Market and meet all listing requirements by July 15, 2024. The company has addressed previous compliance issues and plans to resolve remaining deficiencies through a business combination and other measures.
The extension granted by the Nasdaq Hearings Panel is a positive development for VSAC, indicating progress towards resolving its compliance issues and maintaining its Nasdaq listing. The planned business combination with Mediforum and other measures to address the market value and total holders requirements are likely to be viewed positively by investors, potentially leading to a short-term positive impact on VSAC's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100